Recurrent Rectal Cancer: Clinical Trials

7 trials for Recurrent Rectal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Terminated 7
Phase 21Terminated 1

Follow Recurrent Rectal Cancer: new trials by email Literature Review of Recurrent Rectal Cancer trials Research Report on Recurrent Rectal Cancer

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver
irinotecan-eluting beads, hepatic artery embolization - Liver Metastases, Mucinous Adenocarcinoma of the Colon
Phase 1TerminatedFox Chase Cancer Center22016-01-292018-02-26
Ipilimumab and Local Radiation for Selected Solid Tumors
Ipilimumab, Radiation therapy - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Phase 1TerminatedStanford University32013-02-012024-01-24
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
veliparib, capecitabine, oxaliplatin - Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach
Phase 1TerminatedNational Cancer Institute (NCI)162010-10-012014-04-02
Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy
panobinostat, fluorouracil, leucovorin calcium - Recurrent Colon Cancer, Recurrent Rectal Cancer
Phase 1TerminatedUniversity of Southern California72010-10-012015-05-27
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
irinotecan-eluting beads, hepatic artery embolization - Liver Metastases, Mucinous Adenocarcinoma of the Colon
Phase 1TerminatedFox Chase Cancer Center42010-10-012021-12-20
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
recombinant fowlpox-CEA(6D)/TRICOM vaccine, recombinant vaccinia-CEA(6D)-TRICOM vaccine, docetaxel - Extensive Stage Small Cell Lung Cancer, Recurrent Colon Cancer
Phase 1TerminatedNational Cancer Institute (NCI)602004-06-012014-03-31
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
fluorouracil, sodium phenylbutyrate, indomethacin - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)461997-05-012013-02-01

Narrower conditions

Colonic Neoplasms (7)  ·  Rectal Neoplasms (7)  ·  Breast Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Intraocular Lymphoma (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)

Broader conditions

Colonic Diseases (7)  ·  Colorectal Neoplasms (7)  ·  Digestive System Diseases (7)  ·  Digestive System Neoplasms (7)  ·  Gastrointestinal Diseases (7)  ·  Gastrointestinal Neoplasms (7)  ·  Intestinal Diseases (7)  ·  Intestinal Neoplasms (7)  ·  Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Rectal Diseases (7)  ·  Neoplasms by Histologic Type (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Adnexal Diseases (1)

Interventions

Fluorouracil (2)  ·  4-phenylbutyric acid (1)  ·  Amplified Fragment Length Polymorphism Analysis (1)  ·  Biopsy (1)  ·  Blotting, Western (1)  ·  CTLA-4 Antigen (1)  ·  Capecitabine (1)  ·  Docetaxel (1)  ·  Gene Expression Profiling (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Indomethacin (1)  ·  Interferon-gamma (1)  ·  Ipilimumab (1)  ·  Leucovorin (1)  ·  Oxaliplatin (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Fox Chase Cancer Center (2)  ·  Stanford University (1)  ·  University of Southern California (1)

Countries

United States (7)

Top investigators

Efrat Dotan (1)  ·  Efrat Dotan, MD (1)  ·  George A. Fisher, MD, PhD (1)  ·  Heinz-Josef Lenz (1)  ·  John Marshall (1)  ·  Max Sung (1)  ·  William Schelman (1)

NIH funding

P30CA006927 (1), P30CA014520 (1), P30CA051008 (1), R01CA088972 (1), U01CA062491 (1)